ACCTIVATE Study: Improving Telehealth for Diabetes Management
This study, called ACCTIVATE, is looking at ways to help people with diabetes better use telehealth (healthcare services delivered remotely, like video calls). It tests two main approaches: Digital Health Coaching, which helps patients learn digital skills and use telehealth tools, and Practice Facilitation, which supports clinics in addressing differences in telehealth use among patients. The goal is to see if these interventions can improve your diabetes control (measured by A1C, a blood test that shows average blood sugar levels) and how often you use patient portals. You might be able to join if you are 18 or older, speak English or Spanish, have uncontrolled diabetes (A1C of 8.0% or higher), and have visited a participating clinic at least twice in the last two years. The study aims to enroll 600 participants.
- Study design
- This is an interventional study with a planned enrollment of 600 participants. It is testing two interventions: Digital Health Coaching for patients and Practice Facilitation for clinics.
- What's involved
- Participants will have their A1C and patient portal use measured at the start of the study, and then again at 3, 6, and 12 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 12 months, with measurements taken at 3, 6, and 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Achieving Chronic Care equiTy by leVeraging the Telehealth Ecosystem
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Delphine Tuot, MD MAS · PRINCIPAL_INVESTIGATOR · University of California, San Francisco
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in Patient-Level Hemoglobin A1CBaseline, month 3, month 6, and month 12
Change in A1C (%) will be determined by subtracting month 3, 6, and 12 A1C values from baseline A1C
- Change in Patient Portal UseBaseline, month 3, month 6, and month 12
The average number of patient portal log-ins per month will be obtained from the EHR